Navigation Links
Pioneer in neural development honored with the Mortimer D. Sackler, M.D. Prize
Date:2/19/2013

NEW YORK, NY (February 19, 2013) Columbia University College of Physicians and Surgeons and Weill Cornell Medical College have announced that the Mortimer D. Sackler, M.D. Prize for Distinguished Achievement in Developmental Psychobiology has been awarded to Carla Shatz, PhD, the Sapp Family Provostial Professor in Neurobiology at Stanford University in Palo Alto, California. Dr. Shatz's work has advanced understanding of fundamental principles of early brain development with the discovery that neuronal activity prior to birth is essential for later formation and refinement of connections in the visual system. Her work has important implications for understanding how the visual system refines its connectionswork that has contributed to our understanding of critical periods of brain wiring in developmental disorders such as autism and schizophrenia.

Dr. Shatz's selection as this year's Sackler Prize recipient is in recognition not only of her pioneering achievements in the understanding of early brain development, but also of her leadership in the field of neuroscience and her track record of mentorship.

"Dr. Shatz has provided some of our most profound insights into the way the brain matures during early life, including the importance of neural activity in shaping development. Her work provides a blueprint for understanding how brain function is molded at very young ages. She is a wonderful pick for the prize that commemorates Dr. Mortimer D. Sackler's legacy and his passion for understanding the biological basis of neuropsychiatric disorders," said Jay Gingrich, MD, PhD, director of the Columbia Sackler Institute and the Sackler Institute Professor of Developmental Psychobiology at Columbia University Medical Center and the New York State Psychiatric Institute.

"I am thrilled about this year's recipient of the prize. Not only has Dr. Shatz provided new insights into early brain development that have important implications for neurodevelopmental disorders, she has been a world-class leader in integrating a multitude of disciplines necessary for understanding the complexities of the human brain. This interdisciplinary approach to bridging disparate scientific viewswith unusual harmonyis a philosophy shared across the Sackler Institutes, as part of Dr. Sackler's vision," said B.J. Casey, PhD, director of the Sackler Institute and the Sackler Professor of Developmental Psychobiology at Weill Cornell Medical College.

The Sackler Prize is selected by a committee of 15, including faculty from each of the six Sackler Institutes, programs, and centers: Weill Cornell Medical College; Columbia University Medical Center; Universities of Edinburgh, Glasgow; University of Sussex; King's College London; and McGill University. Dr. Shatz will hold grand rounds at Columbia and Weill Cornell at the end of February and the beginning of March.

Dr. Shatz said, "I am thrilled and honored to receive this wonderful recognition from the Sackler Institutes in the name of this distinguished family. Understanding fundamental mechanisms of brain development and the dynamic interplay between nature and nurture are essential for treating, and someday curing, neurodevelopmental disorders such as autism and schizophrenia."

Asked about the most unexpected insight from her own work, she said, "Discovering that nerve cells in the baby's brain spontaneously send signals from the eye to the brain's visual centers long before vision. It is as if the brain is running test patterns and rehearsing for vision long before birth, and we know that this rehearsal is a key part of brain-circuit tuning during development."

Dr. Shatz is director of Bio-X, Stanford University's pioneering interdisciplinary biosciences program that brings together faculty from across the entire universityclinicians, biologists, engineers, physicists, and computer scientiststo unlock the secrets of the human body in health and disease.

In 1976, Dr. Shatz was the first woman to earn a PhD in neurobiology at Harvard Medical School, where she studied with Nobel laureates David Hubel and Torsten Wiesel. In 1978, she joined the faculty as assistant professor of neurobiology at Stanford, where she was the first woman to receive tenure in the basic sciences.

Dr. Shatz is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the American Philosophical Society, and the Institute of Medicine and was recently elected as a Foreign Member of the Royal Society of London. She has been a Howard Hughes investigator and received numerous awards, including the Gill Prize in Neuroscience, the Society for Neuroscience's Salpeter Lifetime achievement award, and the Ralph Gerard Prize in Neuroscience.

The Mortimer D. Sackler, M.D. Prize for Distinguished Achievement in Developmental Psychobiology

The Mortimer D. Sackler, M.D. Prize for Distinguished Achievement in Developmental Psychobiology recognizes researchers who have advanced our understanding of the developmental processes of mind, brain, and behavior that contribute to normal development and of the origins of mental illness. The prize aims to foster international cooperation among scientists and promote public understanding of their work. The prize is presented jointly every two years by the Sackler Institute for Developmental Psychobiology at Columbia University College of Physicians and Surgeons and the Sackler Institute for Developmental Psychobiology at Weill Cornell Medical College. The first prize was awarded in 2008 to Dr. Avshalom Caspi of King's College, London, and Duke University. Dr. Fernando Nottebohm of the Rockefeller University received the prize in 2010.

The prize honors one of the most creative scientists in the field of developmental psychobiology, the late Mortimer D. Sackler, M.D., who began his career as a psychiatrist and pioneer researcher in biological psychiatry in the late 1940s at the New York State Department of Mental Health. During this early period, he published more than 40 papers in peer-reviewed journals, which highlighted the role of early childhood development in later psychiatric illness. In the early 1950s, Dr. Sackler, with his brothers, founded the pharmaceutical company known today as Purdue Pharma. The original prize was a gift in honor of Dr. Sackler's 90th birthday from his seven children, and the prize was endowed in 2009 by a gift from The Mortimer D. Sackler Foundation, Inc.

The Sackler Institutes at Weill Cornell Medical College and Columbia University Medical Center

The Sackler Institute for Developmental Psychobiology was endowed and established at Columbia University Medical Center in 2000 by the Sackler FoundationLa Fondation Sackler and is dedicated to research into the complex processes underlying normal development as well as the origins of psychiatric illness, working at levels ranging from the molecular to the psychological.

The Sackler Institute for Developmental Psychobiology at Weill Cornell Medical College, established and endowed in 1996 by the Sackler FoundationLa Fondation Sackler and Mortimer D. Sackler, M.D., family members and related entities, is focused on research and training using state-of-the-art brain-imaging techniques, human and mouse genetics, and novel behavioral methods to study typical and atypical human brain development.


'/>"/>

Contact: Karin Eskenazi
ket2116@columbia.edu
212-342-0508
Columbia University Medical Center
Source:Eurekalert

Related biology news :

1. Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
2. UCSB researchers perform pioneering research on Type 2 diabetes
3. Pioneering researcher receives Heart Association Lifetime Achievement Award
4. Stanford bioengineer Christina Smolke wins NIH Directors Pioneer Award
5. 2 pioneering plant genomics efforts given a funding boost by National Science Foundation
6. Project MICREAgents: Self-assembling smart microscopic reagents to pioneer pourable electronics
7. Pioneering self-contained smart village offers world model for rural poverty relief
8. BGI, GE Healthcare team up on pioneering stem cell science projects
9. Good news for nanomedicine: Quantum dots appear safe in pioneering study on primates
10. March of Dimes awards $250,000 prize to 2 scientists who pioneered advances in skin disorders
11. Space research institute honors Sen. Hutchison with Pioneer Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
(Date:11/14/2016)... -- xG Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, ... use in challenging operating environments, announced its results for ... hold a conference call to discuss these results on ... below). Key Recent Accomplishments ... to acquire Vislink Communication Systems. The purchase is expected ...
Breaking Biology News(10 mins):
(Date:12/9/2016)... 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... to announce that Biohaven has issued today the following ... (PRWEB) Dec 9, 2016 - Biohaven Pharmaceutical ... that the U.S. Food and Drug Administration ("FDA") has ... drug candidate BHV-0223, an orally dissolving tablet being developed ...
(Date:12/8/2016)... 8, 2016  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... intratumoral cancer immunotherapies, today announced financial results for ... "We are delivering on our commitment to address ... IL-12. We are pleased with the early clinical ... and we are focused on advancing our lead ...
(Date:12/8/2016)... , Dec. 8, 2016 Eurofins announces the appointment ... and President of Eurofins Scientific Inc. (ESI). Mr. ... his proven professional and entrepreneurial experience in leading international business teams. ... US food testing market to uphold Eurofins, status as the global ... ...
(Date:12/8/2016)...  Anaconda BioMed S.L., a pre-clinical stage medical device ... neuro-thrombectomy system for the treatment of Acute Ischemic Stroke ... to join its Scientific Advisory Board (SAB). The SAB ... scientific and clinical experts to Anaconda BioMed S.L., as ... ® to its clinical phase. The SAB is ...
Breaking Biology Technology: